Citation tools

Rossignol, Patrick, and João Pedro Ferreira. "Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients." JACC: Heart Failure 7.1 (2019): 33-35. Web. 22 Jan. 2019.
Advertisement